达雷妥尤单抗用于难治性温抗体型自身免疫性溶血性贫血 - Suppr

Suppr

超能文献

Daratumumab for refractory warm autoimmune hemolytic anemia.

作者信息

Jain Ankur, Gupta D K

机构信息

Department of Haematology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, 110029, India.

出版信息

Ann Hematol. 2021 May;100(5):1351-1353. doi: 10.1007/s00277-020-04063-w. Epub 2020 May 14.

DOI:10.1007/s00277-020-04063-w

PMID:32405694

Abstract

摘要

相似文献

Daratumumab for refractory warm autoimmune hemolytic anemia.达雷妥尤单抗用于难治性温抗体型自身免疫性溶血性贫血

Ann Hematol. 2021 May;100(5):1351-1353. doi: 10.1007/s00277-020-04063-w. Epub 2020 May 14.

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).使用阿仑单抗（人源化CD52单克隆抗体）治疗B细胞慢性淋巴细胞白血病中的严重难治性自身免疫性溶血性贫血。

Leukemia. 2007 Mar;21(3):511-4. doi: 10.1038/sj.leu.2404512. Epub 2007 Jan 11.

Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.阿仑单抗使对皮质类固醇、脾切除术及利妥昔单抗均难治的自身免疫性溶血性贫血完全缓解。

Haematologica. 2006 May;91(5 Suppl):ECR13.

Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment.混合性温抗体型与冷抗体型自身免疫性溶血性贫血：利妥昔单抗治疗2个疗程后完全缓解

Blood. 2002 May 1;99(9):3478-9. doi: 10.1182/blood-2002-01-0018.

Warm autoimmune hemolytic anemia following recurrent mycoplasma pneumonia infections in a child with Down syndrome.一名唐氏综合征患儿反复感染支原体肺炎后发生温抗体型自身免疫性溶血性贫血。

Pediatr Hematol Oncol. 2008 Sep;25(7):693-8. doi: 10.1080/08880010802237492.

Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.难治性温热型IgM介导的自身免疫性溶血性贫血合并Churg-Strauss综合征，对依库珠单抗和利妥昔单抗治疗有效。

Am J Hematol. 2015 Jan;90(1):78-81. doi: 10.1002/ajh.23791. Epub 2014 Jul 11.

Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.两例使用利妥昔单抗治疗的难治性温抗体型自身免疫性溶血性贫血病例。

Am J Hematol. 2005 Feb;78(2):123-6. doi: 10.1002/ajh.20220.

Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.抗CD20单克隆抗体治疗儿童由温反应性免疫球蛋白A、免疫球蛋白G和免疫球蛋白M自身抗体引起的严重自身免疫性溶血性贫血的成功病例报告

J Med Case Rep. 2017 Nov 14;11(1):321. doi: 10.1186/s13256-017-1449-2.

The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease.达雷妥尤单抗在冷凝集素病患者中的免疫调节作用和临床疗效。

Front Immunol. 2021 Mar 1;12:649441. doi: 10.3389/fimmu.2021.649441. eCollection 2021.

A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.利妥昔单抗联合环磷酰胺和地塞米松治疗复发/难治性温抗体自身免疫性溶血性贫血的回顾性研究。

Acta Haematol. 2020;143(3):244-249. doi: 10.1159/000501538. Epub 2019 Oct 30.

引用本文的文献

Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia - Case Report.达雷妥尤单抗与罗米司亭联合治疗长期难治性原发性免疫性血小板减少症——病例报告

Immunotargets Ther. 2025 Jan 6;14:1-5. doi: 10.2147/ITT.S487895. eCollection 2025.

Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease.达雷妥尤单抗单药治疗难治性温抗体自身免疫性溶血性贫血和冷凝集素病。

Blood Adv. 2024 Jun 11;8(11):2622-2634. doi: 10.1182/bloodadvances.2024012585.

The Role of the Spleen and the Place of Splenectomy in Autoimmune Hemolytic Anemia-A Review of Current Knowledge.脾脏的作用及脾切除术在自身免疫性溶血性贫血中的地位——当前知识综述

Diagnostics (Basel). 2023 Sep 9;13(18):2891. doi: 10.3390/diagnostics13182891.

Rituximab resistance in ITP and beyond.ITP 及其他疾病中的利妥昔单抗耐药。

Front Immunol. 2023 Jul 28;14:1215216. doi: 10.3389/fimmu.2023.1215216. eCollection 2023.

Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia.病例报告：移植前同种免疫和严重溶血性贫血的达妥木单抗治疗。

Front Immunol. 2022 Nov 29;13:1055473. doi: 10.3389/fimmu.2022.1055473. eCollection 2022.

Development of New Drugs for Autoimmune Hemolytic Anemia.自身免疫性溶血性贫血新药的研发

Pharmaceutics. 2022 May 11;14(5):1035. doi: 10.3390/pharmaceutics14051035.

Refractory autoimmune hemolytic anemia in a systemic lupus erythematosus patient: A clinical case report.系统性红斑狼疮患者的难治性自身免疫性溶血性贫血：一例临床病例报告

Clin Case Rep. 2022 Mar 18;10(3):e05583. doi: 10.1002/ccr3.5583. eCollection 2022 Mar.

Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia.达雷妥尤单抗，一种治疗多重难治性自身免疫性血细胞减少症的全新方法。

Haematologica. 2021 Dec 1;106(12):3198-3201. doi: 10.3324/haematol.2021.279232.

Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.病例报告：达雷妥尤单抗靶向浆细胞重置抗磷脂综合征的体液免疫反应。

Front Immunol. 2021 Apr 12;12:667515. doi: 10.3389/fimmu.2021.667515. eCollection 2021.

The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease.达雷妥尤单抗在冷凝集素病患者中的免疫调节作用和临床疗效。

Front Immunol. 2021 Mar 1;12:649441. doi: 10.3389/fimmu.2021.649441. eCollection 2021.

本文引用的文献

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.蛋白酶体抑制剂PS-341可抑制人多发性骨髓瘤细胞的生长、诱导其凋亡并克服耐药性。

Cancer Res. 2001 Apr 1;61(7):3071-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验